392 related articles for article (PubMed ID: 24954801)
1. The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.
Dusek P; Roos PM; Litwin T; Schneider SA; Flaten TP; Aaseth J
J Trace Elem Med Biol; 2015; 31():193-203. PubMed ID: 24954801
[TBL] [Abstract][Full Text] [Related]
2. Transcranial sonography in brain disorders with trace metal accumulation.
Walter U
Int Rev Neurobiol; 2010; 90():166-78. PubMed ID: 20692501
[TBL] [Abstract][Full Text] [Related]
3. Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?
Johnson S
Med Hypotheses; 2001 Feb; 56(2):171-3. PubMed ID: 11425282
[TBL] [Abstract][Full Text] [Related]
4. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
[TBL] [Abstract][Full Text] [Related]
5. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats.
Tarohda T; Ishida Y; Kawai K; Yamamoto M; Amano R
Anal Bioanal Chem; 2005 Sep; 383(2):224-34. PubMed ID: 16132122
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Weiskirchen S; Matusch A; Stremmel W; Weiskirchen R
BMC Neurosci; 2014 Aug; 15():98. PubMed ID: 25142911
[TBL] [Abstract][Full Text] [Related]
7. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
8. Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease.
Kim JM; Ko SB; Kwon SJ; Kim HJ; Han MK; Kim DW; Cho SS; Jeon BS
Neurosci Lett; 2005 Jul 1-8; 382(1-2):143-7. PubMed ID: 15911138
[TBL] [Abstract][Full Text] [Related]
9. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
10. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
11. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
Davies KM; Mercer JF; Chen N; Double KL
Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
[TBL] [Abstract][Full Text] [Related]
12. Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.
Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL
Metallomics; 2017 Oct; 9(10):1447-1455. PubMed ID: 28944802
[TBL] [Abstract][Full Text] [Related]
13. Copper toxicity induced hepatocerebral and neurodegenerative diseases: an urgent need for prognostic biomarkers.
Pal A
Neurotoxicology; 2014 Jan; 40():97-101. PubMed ID: 24342654
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
Yokel RA
J Alzheimers Dis; 2006 Nov; 10(2-3):223-53. PubMed ID: 17119290
[TBL] [Abstract][Full Text] [Related]
15. The effect of subcutaneous tetrathiomolybdate administration on copper and iron metabolism, including their regional redistribution in the brain, in the Long-Evans Cinnamon rat, a bona fide animal model for Wilson's disease.
Sugawara N; Ikeda T; Lai YR; Sugawara C
Pharmacol Toxicol; 1999 May; 84(5):211-7. PubMed ID: 10361977
[TBL] [Abstract][Full Text] [Related]
16. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
Sato M; Hayashi A; Ito H; Tojo M; Arima M
No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
[TBL] [Abstract][Full Text] [Related]
17. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
18. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease.
Li Y; Togashi Y; Sato S; Emoto T; Kang JH; Takeichi N; Kobayashi H; Kojima Y; Une Y; Uchino J
J Clin Invest; 1991 May; 87(5):1858-61. PubMed ID: 2022751
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism.
Bonilla-Ramirez L; Jimenez-Del-Rio M; Velez-Pardo C
Biometals; 2011 Dec; 24(6):1045-57. PubMed ID: 21594680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
